Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

Featured Research

New ideas and innovations in drug discovery

Outsourcing AI For Drug Discovery: Independent Expertise Is Key To Avoid Overhyped Claims

   by Mostapha Benhenda    11100
Outsourcing AI For Drug Discovery: Independent Expertise Is Key To Avoid Overhyped Claims

Investments in artificial intelligence (AI) for drug discovery are surging. Big Pharmas are throwing big bucks at AI. Sanofi signed a 300 Million dollars deal with the Scottish AI startup Exscentia, and GSK did the same for 42 Million dollars. Also, the Silicon Valley VC firm Andreessen Horowitz launched a new 450 Million dollars bio investment fund, with one focus area in applications of AI to drug discovery.

In this craze, lots of pharma and biotech decision-makers wonder whether they should jump on the bandwagon, or wait and see.

Unveiling Hidden Drug Targets

   by Andrii Buvailo    4615
Unveiling Hidden Drug Targets

Scientists estimated that the human genome encodes above 20,000 different proteins in our body. However, available public databases contain records of known ligands for only about 10% of all proteins. Expanding the map of “druggable” proteins increases the chances of running into novel small molecule drugs.

A recent study, published in Cell, opens doors for unveiling novel drug targets and even reconsidering some of the known protein targets, previously tagged “undruggable”.

Learning From Nature: New Antibiotics Found In Our Body

   by Andrii Buvailo    3020
Learning From Nature: New Antibiotics Found In Our Body

To date, nature has been the best teacher for drug discovery scientists, especially for those who develop antimicrobial drugs. Lately, a new example proving this notion emerged in press - a recent publication in a prestigious research journal Nature describing a new powerful method of identifying yet unknown classes of antibiotics by learning from bacteria living in our body - microbiota.